Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895916498> ?p ?o ?g. }
- W2895916498 endingPage "674" @default.
- W2895916498 startingPage "666" @default.
- W2895916498 abstract "The importance of assessing the probability of venous thromboembolism recurrence, a condition that includes deep vein thrombosis and pulmonary embolism, lies in the fact that it is the most important factor in deciding the duration of anticoagulant treatment. Risk of recurrence depends mostly on the presence of a risk factor for developing venous thromboembolism, with patients with unprovoked events being at the higher risk of recurrence. The risk of recurrence needs to be balanced with the risk of bleeding and the potential severity of these thrombotic and hemorrhagic events. In patients with an unprovoked venous thromboembolism who complete treatment for the acute (first 10 days) and post-acute phase of the disease (from day 10 to 3–6 months), the decision has to be made regarding prolonged antithrombotic therapy to prevent recurrences. The main goal of extended treatment is preventing recurrences with a safety profile in terms of bleeding risk. Many therapeutic options are now available for these patients, including antiplatelet therapy with aspirin or direct oral anticoagulants. Moreover, apixaban and rivaroxaban at prophylactic doses have demonstrated efficacy in preventing recurrences with a low risk of bleeding.Key messagesExtending treatment (longer than 3–6 months) is challenging in patients with venous thromboembolism (VTE) and depend on the risk of venous thromboembolism recurrence, the bleeding risk and patient and physician preferences.Anticoagulation treatment should be stopped in patients with provoked VTE and in those with unprovoked VTE and a high bleeding risk after an initial period of 3–6 months.There are some therapeutic alternatives (including Aspirin and low dose of some NOACs) to reduce venous thromboembolism recurrence risk in patients with unprovoked VTE and a low bleeding risk for extended treatment of VTE (after an initial period of 3–6 months)." @default.
- W2895916498 created "2018-10-26" @default.
- W2895916498 creator A5005702788 @default.
- W2895916498 creator A5008363748 @default.
- W2895916498 creator A5013418684 @default.
- W2895916498 creator A5028375900 @default.
- W2895916498 creator A5035512968 @default.
- W2895916498 creator A5036205446 @default.
- W2895916498 creator A5070571464 @default.
- W2895916498 creator A5088995310 @default.
- W2895916498 date "2018-11-17" @default.
- W2895916498 modified "2023-10-01" @default.
- W2895916498 title "Update on extended treatment for venous thromboembolism" @default.
- W2895916498 cites W1587599877 @default.
- W2895916498 cites W1634950970 @default.
- W2895916498 cites W1808477918 @default.
- W2895916498 cites W1917847000 @default.
- W2895916498 cites W1924958570 @default.
- W2895916498 cites W1964644585 @default.
- W2895916498 cites W1975990989 @default.
- W2895916498 cites W1984833612 @default.
- W2895916498 cites W1986777349 @default.
- W2895916498 cites W2001497857 @default.
- W2895916498 cites W2009013630 @default.
- W2895916498 cites W2010481138 @default.
- W2895916498 cites W2016492461 @default.
- W2895916498 cites W2016907231 @default.
- W2895916498 cites W2054515228 @default.
- W2895916498 cites W2059305858 @default.
- W2895916498 cites W2067741035 @default.
- W2895916498 cites W2070112905 @default.
- W2895916498 cites W2074708727 @default.
- W2895916498 cites W2076621544 @default.
- W2895916498 cites W2102778065 @default.
- W2895916498 cites W2110134277 @default.
- W2895916498 cites W2112378432 @default.
- W2895916498 cites W2112757583 @default.
- W2895916498 cites W2115787552 @default.
- W2895916498 cites W2131099415 @default.
- W2895916498 cites W2138438886 @default.
- W2895916498 cites W2149388786 @default.
- W2895916498 cites W2160053078 @default.
- W2895916498 cites W2160625453 @default.
- W2895916498 cites W2162531249 @default.
- W2895916498 cites W2166402206 @default.
- W2895916498 cites W2167149931 @default.
- W2895916498 cites W2225937646 @default.
- W2895916498 cites W2284010705 @default.
- W2895916498 cites W2307552230 @default.
- W2895916498 cites W2336061167 @default.
- W2895916498 cites W2399148243 @default.
- W2895916498 cites W2468459421 @default.
- W2895916498 cites W2529469085 @default.
- W2895916498 cites W2558457364 @default.
- W2895916498 cites W2568332688 @default.
- W2895916498 cites W2572729871 @default.
- W2895916498 cites W2595086780 @default.
- W2895916498 cites W2595581694 @default.
- W2895916498 cites W2771553990 @default.
- W2895916498 cites W2775434460 @default.
- W2895916498 cites W2792485334 @default.
- W2895916498 cites W2802130786 @default.
- W2895916498 doi "https://doi.org/10.1080/07853890.2018.1538564" @default.
- W2895916498 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30345825" @default.
- W2895916498 hasPublicationYear "2018" @default.
- W2895916498 type Work @default.
- W2895916498 sameAs 2895916498 @default.
- W2895916498 citedByCount "14" @default.
- W2895916498 countsByYear W28959164982019 @default.
- W2895916498 countsByYear W28959164982020 @default.
- W2895916498 countsByYear W28959164982021 @default.
- W2895916498 countsByYear W28959164982022 @default.
- W2895916498 crossrefType "journal-article" @default.
- W2895916498 hasAuthorship W2895916498A5005702788 @default.
- W2895916498 hasAuthorship W2895916498A5008363748 @default.
- W2895916498 hasAuthorship W2895916498A5013418684 @default.
- W2895916498 hasAuthorship W2895916498A5028375900 @default.
- W2895916498 hasAuthorship W2895916498A5035512968 @default.
- W2895916498 hasAuthorship W2895916498A5036205446 @default.
- W2895916498 hasAuthorship W2895916498A5070571464 @default.
- W2895916498 hasAuthorship W2895916498A5088995310 @default.
- W2895916498 hasBestOaLocation W28959164981 @default.
- W2895916498 hasConcept C126322002 @default.
- W2895916498 hasConcept C141071460 @default.
- W2895916498 hasConcept C177713679 @default.
- W2895916498 hasConcept C2776265017 @default.
- W2895916498 hasConcept C2776301958 @default.
- W2895916498 hasConcept C2777015399 @default.
- W2895916498 hasConcept C2777628954 @default.
- W2895916498 hasConcept C2778205648 @default.
- W2895916498 hasConcept C2778661090 @default.
- W2895916498 hasConcept C2779161974 @default.
- W2895916498 hasConcept C2780011451 @default.
- W2895916498 hasConcept C2780638905 @default.
- W2895916498 hasConcept C2780868729 @default.
- W2895916498 hasConcept C2991741193 @default.
- W2895916498 hasConcept C50440223 @default.
- W2895916498 hasConcept C71924100 @default.